Epizyme, Inc.
PRMT5 INHIBITORS AND USES THEREOF

Last updated:

Abstract:

Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

2 Mar 2021

Issue date:

7 Oct 2021